Charles River Laboratorie (CRL) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $295.19 +1.28%
Financial Fact:
Net income attributable to common shareowners: 37.74M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income attributable to common shareowners: 37.74M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Charles River Laboratorie (NYSE: CRL) reported Q1 EPS of $0.79, $0.03 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $320.4 million versus the consensus estimate of $324 million.
Charles River Laboratorie sees FY2015 EPS of $3.55-$3.65, versus the consensus of $3.60.
For earnings history and earnings-related data on Charles River Laboratorie (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
